FI901154A0 - Förfarande för framställning av terapeutiskt verksamma 3-acylamino-2-oxo-1H-2,3-dihydro-1,4-bensodiazepinföreningar - Google Patents

Förfarande för framställning av terapeutiskt verksamma 3-acylamino-2-oxo-1H-2,3-dihydro-1,4-bensodiazepinföreningar

Info

Publication number
FI901154A0
FI901154A0 FI901154A FI901154A FI901154A0 FI 901154 A0 FI901154 A0 FI 901154A0 FI 901154 A FI901154 A FI 901154A FI 901154 A FI901154 A FI 901154A FI 901154 A0 FI901154 A0 FI 901154A0
Authority
FI
Finland
Prior art keywords
lower alkyl
represents hydrogen
halogen
preparation
acylamino
Prior art date
Application number
FI901154A
Other languages
English (en)
Finnish (fi)
Other versions
FI92486C (sv
FI92486B (sv
Inventor
Harald Waldeck
Werner Benson
Horst Zeugner
Klaus-Ullrich Wolf
Peter-Colin Gregory
Derk Hamminga
Van Ineke Wijngaarden
Original Assignee
Kali Chemie Pharma Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE3907390A external-priority patent/DE3907390A1/de
Priority claimed from DE3907389A external-priority patent/DE3907389A1/de
Application filed by Kali Chemie Pharma Gmbh filed Critical Kali Chemie Pharma Gmbh
Publication of FI901154A0 publication Critical patent/FI901154A0/sv
Application granted granted Critical
Publication of FI92486B publication Critical patent/FI92486B/sv
Publication of FI92486C publication Critical patent/FI92486C/sv

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/06—Peri-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/06—Peri-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/06—Peri-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Indole Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
FI901154A 1989-03-08 1990-03-07 Förfarande för framställning av terapeutiskt verksamma 3-acylamino-2-oxo-1H-2,3-dihydro-1,4-bensodiazepinföreningar FI92486C (sv)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
DE3907389 1989-03-08
DE3907390A DE3907390A1 (de) 1989-03-08 1989-03-08 Neue 1,7-anellierte 1h-indol-2-carbonsaeure-n-(5-phenyl-1,4-benzodiazepin-3-yl)amide
DE3907390 1989-03-08
DE3907389A DE3907389A1 (de) 1989-03-08 1989-03-08 Neue 1,7-anellierte 1h-indol-carbonsaeure-n-(5-alkyl-1,4-benzodiazepin-3-yl)amide

Publications (3)

Publication Number Publication Date
FI901154A0 true FI901154A0 (sv) 1990-03-07
FI92486B FI92486B (sv) 1994-08-15
FI92486C FI92486C (sv) 1994-11-25

Family

ID=25878542

Family Applications (1)

Application Number Title Priority Date Filing Date
FI901154A FI92486C (sv) 1989-03-08 1990-03-07 Förfarande för framställning av terapeutiskt verksamma 3-acylamino-2-oxo-1H-2,3-dihydro-1,4-bensodiazepinföreningar

Country Status (20)

Country Link
US (1) US5010076A (sv)
EP (1) EP0387618B1 (sv)
JP (1) JP3010558B2 (sv)
KR (1) KR920003627B1 (sv)
CN (1) CN1032208C (sv)
AT (1) ATE109146T1 (sv)
AU (1) AU616835B2 (sv)
CS (1) CS390091A3 (sv)
DE (1) DE59006544D1 (sv)
DK (1) DK0387618T3 (sv)
ES (1) ES2057216T3 (sv)
FI (1) FI92486C (sv)
HK (1) HK1006570A1 (sv)
HU (2) HU207317B (sv)
IE (1) IE65030B1 (sv)
IL (1) IL93401A (sv)
NO (1) NO173869C (sv)
NZ (1) NZ232774A (sv)
PH (1) PH26955A (sv)
PT (1) PT93360B (sv)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH07103105B2 (ja) * 1989-05-12 1995-11-08 杏林製薬株式会社 インドール誘導体及びその製造方法
US5264419A (en) * 1990-08-31 1993-11-23 Warner-Lambert Company N-substituted cycloalkyl and polycycloalkyl α-substituted TRP derivatives
CA2068355A1 (en) * 1991-05-14 1992-11-15 Mark S. Chambers Benzodiazephine derivatives, compositions containing them and their use in therapy
DE4128015A1 (de) * 1991-08-23 1993-02-25 Kali Chemie Pharma Gmbh 1,7-anellierte 2-(piperazinoalkyl)indol-derivate sowie verfahren und zwischenprodukte zu ihrer herstellung und diese verbindugnen enthaltende arzneimittel
GB9203790D0 (en) * 1992-02-21 1992-04-08 Merck Sharp & Dohme Therapeutic agents
US5360802A (en) * 1992-05-11 1994-11-01 Merck Sharpe & Dohme Ltd. Benzodiazepine derivatives, compositions containing them and their use in therapy
DE4304806A1 (de) * 1993-02-17 1994-08-18 Kali Chemie Pharma Gmbh 5-Phenyl-pyrrolo-1,4-benzoxazin- und -thiazin-Derivate sowie Verfahren und Zwischenprodukte zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
US5556969A (en) * 1994-12-07 1996-09-17 Merck Sharp & Dohme Ltd. Benzodiazepine derivatives
NZ314105A (en) * 1996-02-02 1997-12-19 Sumitomo Pharma Guanidine derivative substituted with a substituted indole which is peri condensed with a heterocyclic ring
NZ510685A (en) * 1998-09-30 2003-10-31 Takeda Chemical Industries Ltd Drugs for improving vesical excretory strength
CA2446696A1 (fr) * 2001-06-07 2002-12-12 Neuro3D Inhibiteurs des phosphodiesterases des nucleotides cycliques, preparation et utilisations de ces inhibiteurs
FR2846653B1 (fr) * 2002-10-30 2007-04-20 Neuro3D Inhibiteurs des phosphodiesterases des nucleotides cycliques, preparation et utilisations
NZ540167A (en) * 2002-10-30 2007-06-29 Neuro3D Cyclic nucleotide phosphodiesterase inhibitors, preparation and uses
WO2014098000A1 (en) * 2012-12-17 2014-06-26 Daiichi Sankyo Company, Limited Process for preparation of a tricyclic heterocycle

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3471308D1 (en) * 1983-10-17 1988-06-23 Synthelabo Imidazoline derivatives, their preparation and therapeutical use
CA1332410C (en) * 1984-06-26 1994-10-11 Roger M. Freidinger Benzodiazepine analogs
US4820834A (en) * 1984-06-26 1989-04-11 Merck & Co., Inc. Benzodiazepine analogs
FR2567126B1 (fr) * 1984-07-06 1986-12-12 Synthelabo Derives de pyrrolo(1,2,3-de) benzoxazine et benzothiazine, leur preparation et leur application en therapeutique
US4628084A (en) * 1986-01-02 1986-12-09 Merck & Co., Inc. Process for 3-acylamino benzodiazepines
US4985420A (en) * 1987-12-10 1991-01-15 Duphar International Research B.V. 1,7-annelated indolecarboxylic acid esters and -amides
FR2630440B1 (fr) * 1988-04-25 1991-09-20 Jouveinal Sa Benzodiazepines, leur procede et intermediaires de preparation et leurs applications en therapeutique
IL91361A (en) * 1988-09-09 1994-10-07 Fujisawa Pharmaceutical Co Benzodiazepinone compounds [4,1] connected via positions 1 and 9 and carrying two transducers, processes for their preparation and pharmaceutical preparations containing them
FR2652352A1 (fr) * 1989-09-28 1991-03-29 Jouveinal Sa Benzodiazepines, leur procede et intermediaires de preparation et leurs applications en therapeutique.

Also Published As

Publication number Publication date
EP0387618B1 (de) 1994-07-27
HK1006570A1 (en) 1999-03-05
NO901083D0 (no) 1990-03-07
HUT53641A (en) 1990-11-28
IL93401A (en) 1994-08-26
US5010076A (en) 1991-04-23
NO173869C (no) 1994-02-16
CS390091A3 (en) 1992-06-17
AU5075390A (en) 1990-09-13
IL93401A0 (en) 1990-11-29
KR920003627B1 (ko) 1992-05-04
PT93360B (pt) 1996-02-29
AU616835B2 (en) 1991-11-07
HU207317B (en) 1993-03-29
CN1045392A (zh) 1990-09-19
NO173869B (no) 1993-11-08
NZ232774A (en) 1991-04-26
IE900813L (en) 1990-09-08
NO901083L (no) 1990-09-10
KR900014391A (ko) 1990-10-23
DE59006544D1 (de) 1994-09-01
PT93360A (pt) 1990-11-07
HU210354A9 (en) 1995-03-28
ES2057216T3 (es) 1994-10-16
JPH02273678A (ja) 1990-11-08
CN1032208C (zh) 1996-07-03
DK0387618T3 (da) 1994-08-22
JP3010558B2 (ja) 2000-02-21
EP0387618A1 (de) 1990-09-19
PH26955A (en) 1992-12-03
FI92486C (sv) 1994-11-25
IE65030B1 (en) 1995-10-04
ATE109146T1 (de) 1994-08-15
FI92486B (sv) 1994-08-15
HU901333D0 (en) 1990-05-28

Similar Documents

Publication Publication Date Title
FI901154A0 (sv) Förfarande för framställning av terapeutiskt verksamma 3-acylamino-2-oxo-1H-2,3-dihydro-1,4-bensodiazepinföreningar
ES2071334T3 (es) Analogos de anillos fusionados de nitrogeno conteniendo heterociclos no aromaticos.
SE8505715L (sv) Indolderivat
NO164351C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 5-alkyl-l-fenyl-2-piperazinoalkylpyrazolin-3-on-forbindelser.
IT1193608B (it) Derivati di arilossipropanolamina,procedimento per la loro preparazione composizioni farmaceutiche che li contengono e loro impiego terapeutico
PT92494A (pt) Processo para a preparacao de novos derivados do indol
ZA867616B (en) Tetrahydro-beta-carbolines,process for their production and their use as drugs
DE3266521D1 (en) 2-acylaminomethyl-1,4-benzodiazepine derivatives, their preparation and intermediates, and pharmaceutical preparations containing them
ATE6635T1 (de) Biologisch aktive trizyklische amine, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische praeparate.
CA2011658A1 (en) New 1,7-annelated 1h-indole-2-carboxylic acid-n-(1,4-benzodiazepin-3-yl) amides
PL244080A1 (en) Process for preparing novel 1,1-dioxides of 4-hydroxy-2h-1,2-benzothiazine-3-carbonamide
PL245632A1 (en) Process for preparing novel heterocyclic compounds

Legal Events

Date Code Title Description
BB Publication of examined application
TC Name/ company changed in patent

Owner name: SOLVAY PHARMACEUTICALS GMBH

MM Patent lapsed

Owner name: SOLVAY PHARMACEUTICALS GMBH